|Day Low/High||139.30 / 140.24|
|52 Wk Low/High||120.11 / 148.99|
I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.
Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.
We think Abbott Labs is a terrific company, but the stock already has a big premium and that may limit the potential of future gains.
Sharing Progress in Environmental, Social and Governance Practices
PHILADELPHIA, June 3, 2019 /PRNewswire/ -- A Philadelphia jury awarded more than $80 million to a 75-year-old woman in a transvaginal mesh lawsuit against Ethicon, a subsidiary of Johnson & Johnson (NYSE: JNJ).
We initiated a new position in Mastercard and made several ratings and price target changes.
Overblown litigation concerns have scared off many investors, making now a good time to buy.
We are adding to our Lam Research position.
Johnson & Johnson is ordered to pay a $300 million punitive award to a woman who said she contracted cancer through the use of the company's talc-based products.
Jim gives his view on an analyst take that Cisco is a "relative safe haven in this macro backdrop," he provides thoughts on Palo Alto Networks, he discusses Viacom, and much more!
When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.
The current selloff is finally starting to prompt overwrought responses from investors, Jim Cramer says.
Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.
Stocks tumble Wednesday as falling bond yields and a rare earth ban threat by China rattle Wall Street.
Our 'stay the course' plan during these moments is to use scale and look to buy high-quality merchandise (stocks) that we previously sold higher and are now trading at a discount.
Jim Cramer weighs in on how investors can rebalance their portfolios in a volatile market.
Let's take a serious look at the charts and indicators.
Jim discusses yesterday's buys/sells (including Kohl's and Five Below) and this morning's purchase of Johnson & Johnson, and much more!
We believe today's selloff provides us the opportunity to begin to buy back shares we sold higher.
Shares of Teva plummet Tuesday after UBS downgrades the stock to neutral from buy in light of opioid-related litigation.
U.S. stock futures are lower as caution still prevails amid concerns over the fate of trade talks between Washington and Beijing; the French government says it jobs protected needs in order to support the proposed merger of Fiat Chrysler and Renault; Alibaba is considering raising $20 billion through a second listing in Hong Kong, a report says.
Stocks falter on realization that trade war between U.S. and China is about more than soybeans.
Dividend stock investors should look to have at least some exposure to this sector.
Jim Cramer weighs in on why President Trump cares more about 'beating the Chinese' than the earnings reports that we receive from companies.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.